Physicians at Palm Beach Gardens Medical Center are among the first in the United States to offer the minimally invasive MitraClip device as an option for patients suffering from mitral regurgitation (MR).
“Palm Beach Gardens Medical Center is proud to be one of the first hospitals in Palm Beach County to offer patients suffering from mitral valve disease a nonsurgical treatment option,” said Larry Coomes, hospital CEO. “We are confident that the MitraClip device will open new doors for many of our heart failure patients.”
MitraClip, made by Abbott Vascular, repairs the mitral valve without the need for an invasive surgical procedure. The device is delivered to the heart through the femoral vein, a blood vessel in the leg. Once implanted, it allows the heart to pump blood more efficiently, thereby relieving symptoms and improving patients’ quality of life. Patients undergoing MitraClip treatment typically experience shorter recovery times and reduced hospital stays of about three days.
Multiple trials, published reports and registries of patients treated with the MitraClip device consistently demonstrate a positive safety profile, reduction in mitral regurgitation, improvement in symptoms and reduction in hospitalizations for heart failure, even in some of the most ill and debilitated patients. So far, more than 11,000 patients in more than 30 countries have been treated with the MitraClip device.
